Citation only
via Europe PMC
Molecular mechanisms and intervention strategies for age-related macular degeneration.
Zhang RY, Su HM, Ding Y, Zou YY.
International journal of ophthalmology · 2026
Abstract
Age-related macular degeneration (AMD) is a leading ocular disorder that causes irreversible visual impairment and blindness in the elderly population. Accumulating evidence demonstrates that AMD is the end-stage outcome of various retinal degenerative lesions and vascular anomalies. Its core pathogenic mechanisms mainly involve dysfunction and atrophy of retinal pigment epithelium (RPE) cells, choroidal capillary degeneration, pathological choroidal neovascularization (CNV), chronic inflammation, oxidative stress injury, deposition of extracellular substances such as drusen, and genetic predisposition. Given its multifactorial origin and complicated pathophysiological processes, the full molecular regulatory network of AMD has not been fully clarified, which restricts the development of more efficient intervention regimens. This review systematically summarizes the latest research progress concerning the molecular mechanisms of AMD, and comprehensively discusses mainstream and emerging therapeutic strategies, including anti-vascular endothelial growth factor (VEGF) drugs, antioxidant and mineral supplements, photodynamic therapy, and laser therapy, as well as innovative modalities such as gene therapy, stem cell therapy, and targeted regulation of complement and inflammatory pathways. It is intended to provide theoretical basis and research references for in-depth mechanistic exploration, early prevention and precise clinical management of AMD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.18240/ijo.2026.07.20
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
RY, Z., HM, S., Y, D., & YY., Z. (2026). Molecular mechanisms and intervention strategies for age-related macular degeneration. <em>International journal of ophthalmology</em>. https://doi.org/10.18240/ijo.2026.07.20
Vancouver
RY Z, HM S, Y D, YY. Z. Molecular mechanisms and intervention strategies for age-related macular degeneration. International journal of ophthalmology. 2026. doi:10.18240/ijo.2026.07.20.
BibTeX
@article{zhang2026Molecu,
title = {Molecular mechanisms and intervention strategies for age-related macular degeneration.},
author = {Zhang RY and Su HM and Ding Y and Zou YY.},
journal = {International journal of ophthalmology},
year = {2026},
doi = {10.18240/ijo.2026.07.20},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PubMed 2006
Preprint
Age-related macular degeneration (AMD): pathogenesis and therapy.
Nature Medicine 2017
Preprint · OA
cGAS drives noncanonical-inflammasome activation in age-related macular degeneration
Antioxidants (Basel, Switzerland) 2026
Open access · OA
Epigenetic–Mitochondrial–Metabolic Crosstalk in Retinal Pigment Epithelium (RPE) Dysfunction in Age-Related Macular Degeneration (AMD)
Survey of Ophthalmology 1988
Open access · CC-BY
Age-related macular degeneration
Antioxidants (Basel, Switzerland) 2026
Open access · OA
The Environmental Exposome and Age-Related Macular Degeneration: Oxidative Stress as a Molecular Link.
Annals of the New York Academy of Sciences 2005
Citation only